C4 Therapeutics, Inc. — Director's Dealing 2021

Mar 16, 2021

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: C4 Therapeutics, Inc. (CCCC)
CIK: 0001662579
Period of Report: 2021-03-12

Reporting Person: Dubin Glenn (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	770607	Indirect
Common Stock	20000	Indirect

Footnotes

F1: Shares held directly by DF Investment Partners LLC ("DFIP"). The Reporting Person serves as managing member of DFIP and may be deemed to exercise voting and investment power over the shares held by DFIP. The Reporting Person disclaims beneficial ownership of the shares held by DFIP except to the extent of his pecuniary interest therein.

F2: Shares held directly by G&E Dubin Family Foundation. The Reporting Person may be deemed to exercise voting and investment power over the shares held by G&E Dubin Family Foundation and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.